The inodilator levosimendan, in clinical use for over two decades, has been the subject of
extensive clinical and experimental evaluation in various clinical settings beyond its …

Inotropic agents are generally recommended to use in patients with acute decompensated
heart failure (HF) with reduced ejection fraction (HFrEF) concurrent to end-organ …

Hintergrund Levosimendan steigert die myokardiale Kontraktilität ohne relevante Erhöhung
des myozytären Sauerstoffverbrauchs und besitzt kardioprotektive Eigenschaften. Es gibt …

Coronary artery bypass graft (CABG) surgery has been in practice for many decades, and it
is one of the most commonly performed cardiac surgeries worldwide. While there are …

This study was conducted to compare the postoperative outcomes between intra-aortic
balloon pump (IABP) and levosimendan in patients undergoing coronary artery bypass graft …

Objectives: This research aims to compare levosimendan to the intra-aortic balloon pump
(IABP) in impaired left ventricular function patients undergoing on-pump coronary artery …

Background: Coronary artery bypass grafting (CABG) is often complicated by hemodynamic
instability, especially in cases with decreased left ventricular ejection fraction (LVEF) …

Background: Patients undergoing coronary artery bypass surgery (CABG), preoperative left
ventricular insufficiency has been linked to increase mortality and morbidity. Intra-aortic …

Purpose: Post cardiac surgery cardiogenic shock is one of the major life threatening
complications of open heart surgeries. Two modalities are widely used to improve the …